Pegylated liposomal doxorubicin re-challenge in patients with ovarian cancer relapse: a multicenter retrospective study.

Elisa Tripodi, Gennaro Cormio, Ugo De Giorgi, Giorgio Valabrega, Daniela Rubino, Stefano Lepori, Giuseppa Maltese, Ilaria Sabatucci, Domenica Lorusso

Research output: Contribution to journalArticlepeer-review

Original languageUndefined/Unknown
Pages (from-to)153-157
Number of pages5
JournalInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Volume29
DOIs
Publication statusPublished - Jan 1 2019

Keywords

  • Aged
  • Antibiotics
  • Antineoplastic
  • therapeutic use
  • Cystadenocarcinoma
  • Serous
  • drug therapy
  • pathology
  • Doxorubicin
  • analogs & derivatives
  • Endometrial Neoplasms
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Neoplasm Recurrence
  • Local
  • Ovarian Neoplasms
  • Polyethylene Glycols
  • Prognosis
  • Retreatment
  • Retrospective Studies

Cite this